## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `vip-post-surgery` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/vip-post-surgery/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-post-surgery/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/vip-post-surgery/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/vip-post-surgery/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/vip-post-surgery/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/vip-post-surgery/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `vip-post-surgery` v2 · content_hash `92ac0d91636afe95…` · thread_head genesis · 18 DIVs - **thesis (c1):** VIP accelerated wound area recovery and increased migration/proliferation of human bronchial epithelial cells in vitro, effects blocked by VPAC1 antagonist. - c3 [human/active] RNA-Seq in 15 CIRS patients on VIP nasal spray showed shifts in metabolic state and innate immune functions coinciding with healing markers. - c4 [human/active] Aviptadil (VIP analog) in a 60-day RCT for critical COVID-19 respiratory failure was associated with higher survival and respiratory recovery rates versus contr - c2 [preclinical/active] In a mouse abdominal irradiation model, VIP reduced TNF-alpha, mitigated intestinal inflammation and injury scores, and promoted secretory cell expansion. - c5 [mechanistic/active] VIP effects on post-surgery recovery lack large-scale dedicated RCTs; existing human data are limited to small or non-surgical populations. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/vip-post-surgery/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/vip-post-surgery/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `vip-post-surgery` - **title:** VIP for Post-Surgery Recovery: Evidence-Graded Review - **url:** https://miscsubjects.com/a/vip-post-surgery - **register:** source_ledger - **updated:** 2026-07-17T02:43:26.420Z - **tags:** peptide, matrix ## Body ## What's breaking down Post-surgery involves layers of tissue disruption, inflammation, and immune activation at the surgical site. Incisions or resections create mechanical wounds that trigger repair cascades. If inflammation persists or immune balance shifts, healing slows. Autonomic and neuropeptide signaling can also influence local blood flow and tissue response. VIP is discussed in contexts of immune modulation and autonomic regulation rather than direct symptom masking. ## Why VIP might help you If immune or autonomic layers contribute to your post-surgery experience, VIP is studied for pathways tied to tissue responses. One in-vitro study on human bronchial epithelial cells showed VIP accelerated wound closure by promoting cell migration and proliferation via VPAC1 receptors (preclinical). Therefore for you: if local tissue repair processes are relevant after surgery, this points to VIP's association with repair signaling instead of pain suppression. Animal models of intestinal injury after irradiation found VIP reduced inflammatory markers like TNF-alpha and supported epithelial regeneration through secretory cell differentiation (preclinical). Therefore for you: if post-operative gut or barrier integrity plays a role, VIP is examined for those regeneration-related effects. A human cell migration assay indicated faster wound bed repopulation with VIP (preclinical). Therefore for you: if wound margin advancement matters in your recovery, the compound's studied effects align with that layer. ## How these fit together Single-compound focus. VIP targets the immune/autonomic layer noted in the peptide chain. No multi-peptide stack applies here. ## What the evidence actually shows Human data remain limited. One RNA-Seq analysis of 15 CIRS patients receiving VIP nasal spray reported shifts in metabolic and innate immune gene expression coinciding with symptom changes (human, small n). A randomized trial of aviptadil (VIP analog) in critical COVID-19 respiratory failure showed survival and respiratory recovery differences versus standard care (human). No large randomized controlled trials specifically examine VIP for general post-surgical wound healing or recovery. Preclinical work includes a 2006 study where VIP sped recovery of mechanically wounded human bronchial epithelial cells in culture and increased E-cadherin expression (preclinical). A 2024 mouse irradiation model demonstrated VIP mitigated intestinal damage, lowered TNF-alpha, and promoted Lyz1+ cell expansion (preclinical). An earlier bronchial epithelium wound-healing assay confirmed accelerated area closure blocked by VPAC1 antagonist (preclinical). Arthritis mouse models showed reduced incidence and severity with VIP (preclinical). Evidence inventory: 2 small human transcriptomic or trial reports; multiple animal and cell-culture studies; no large human post-surgery RCTs identified. ## What scientists say Researchers note VIP's potential in modulating inflammation and supporting epithelial repair in specific injury models. The bronchial cell studies conclude protective effects mediated partly by VPAC1. The irradiation study highlights promotion of secretory differentiation for regeneration. Broader reviews position VIP as an immunomodulator, but emphasize need for targeted clinical validation beyond current contexts like CIRS or acute respiratory failure. ## What people say on Reddit Discussions of VIP appear mainly in CIRS or mold-related communities, where users describe changes in inflammation, breathing, or energy after nasal spray use. Specific post-surgery threads are scarce; general peptide recovery conversations focus more on compounds like BPC-157 for incisions or soft tissue. Anecdotal reports remain individual and unverified (anecdotal). ## What people say on X Posts reference VIP in contexts of blood flow, immune balance, gut function, and general recovery support. One user described it as potentially versatile for multiple systems. Mentions in mold or chronic symptom threads note low endogenous VIP levels correlating with fatigue or immune issues. No detailed post-operative case reports surfaced in recent searches (anecdotal). ## What we do not know Direct human evidence for VIP accelerating surgical incision healing, reducing post-op scar formation, or shortening recovery timelines is absent. Optimal timing, delivery method, or patient selection post-surgery has not been established in controlled trials. Interactions with standard surgical protocols or other recovery factors remain unstudied at scale. Long-term outcomes beyond short-term markers are unknown. ## Safety and limits VIP has been administered in specific clinical settings such as nasal spray in CIRS cohorts or intravenous analog in ICU trials with reported monitoring of markers. Individual responses vary; any use occurs outside approved indications for post-surgery. Regulatory status, sourcing quality, and suitability for any given surgical recovery are outside the scope of this review. Consult primary medical sources for personal decisions. ## Claims (5) - **c1** [preclinical w=0.5] VIP accelerated wound area recovery and increased migration/proliferation of human bronchial epithelial cells in vitro, effects blocked by VPAC1 antagonist. - who_claims: grok/grok-4.3 - sources: s1 - **c2** [preclinical w=0.5] In a mouse abdominal irradiation model, VIP reduced TNF-alpha, mitigated intestinal inflammation and injury scores, and promoted secretory cell expansion. - who_claims: grok/grok-4.3 - sources: s2 - **c5** [mechanistic w=0.3] VIP effects on post-surgery recovery lack large-scale dedicated RCTs; existing human data are limited to small or non-surgical populations. - who_claims: grok/grok-4.3 - **c3** [human w=0.8] RNA-Seq in 15 CIRS patients on VIP nasal spray showed shifts in metabolic state and innate immune functions coinciding with healing markers. - who_claims: grok/grok-4.3 - sources: s3 - **c4** [human w=0.8] Aviptadil (VIP analog) in a 60-day RCT for critical COVID-19 respiratory failure was associated with higher survival and respiratory recovery rates versus controls. - who_claims: grok/grok-4.3 - sources: s4 ## Voxel graph (5 atoms · 9 edges) - full graph: https://miscsubjects.com/api/articles/vip-post-surgery/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (4) - chain valid: yes · head: `db9f4e0b63048666` ### s1 · pubmed · ok - title: Vasoactive intestinal peptide enhances wound healing and proliferation of human bronchial epithelial cells - url: https://pubmed.ncbi.nlm.nih.gov/16965837/ - summary: 2006 in-vitro study on human bronchial epithelial cell wound healing with VIP. - quote: The results showed that VIP accelerated the recovery of wound area of HBEC. VIP increased the migration and proliferation of HBEC, and these effects were blocked by a VPAC1 receptor antagonist. - claim_ids: c1 - hash: `43f55c6ed049e8e6` ### s2 · pubmed · ok - title: Vasoactive intestinal peptide promotes secretory differentiation and mitigates radiation-induced intestinal injury - url: https://pubmed.ncbi.nlm.nih.gov/39380035/ - summary: 2024 mouse study on VIP in irradiation-induced gut injury. - quote: VIP prominently governs intestinal homeostasis by regulating epithelial progenitor cell proliferation and differentiation and promotes intestinal regeneration following acute irradiation injury. - claim_ids: c2 - hash: `9b3d82ed62ca7557` ### s3 · other · ok - title: RNA-Seq on patients with chronic inflammatory response syndrome (CIRS) treated with vasoactive intestinal peptide (VIP) shows a shift in metabolic state and innate immune functions that coincide with healing - url: https://esmed.org/MRA/mra/article/view/862 - summary: 2016 small human RNA-Seq study in CIRS patients on VIP. - quote: This study surveyed 15 patients... who agreed to have their transcriptomes monitored while receiving off label, exogenous VIP nasal spray treatments. - claim_ids: c3 - hash: `7161d88c24b7b199` ### s4 · pubmed · ok - title: The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure - url: https://pubmed.ncbi.nlm.nih.gov/36044317/ - summary: RCT of VIP analog in COVID respiratory failure (from secondary reports). - quote: Among the 21 patients treated with aviptadil, 19 survived to day 28, compared with 4 of the 24 individuals in the SOC group (90% vs 17%, respectively; P <.0001). - claim_ids: c4 - hash: `db9f4e0b63048666` ## Provenance (2 model passes) - chain valid: yes · head: `04f0024352c0e35a` - write · grok/grok-4.3 · 2026-06-29T22:23 · hash `bf8d0d45fa17` - voxel_divide · owner · 2026-07-17T02:43 · hash `04f0024352c0` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/vip-post-surgery/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/vip-post-surgery/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"vip-post-surgery","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest vip-post-surgery|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim vip-post-surgery|tier|assertion` - **iMessage ask:** `vip-post-surgery|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `vip-post-surgery` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-post-surgery/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/vip-post-surgery/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*